Semaglutide and Tirzepatide work by slowing gastric emptying, increasing feelings of fullness, and reducing hunger
Key research areas include: Tissue Repair : Investigated for accelerating wound healing, tendon, and ligament regeneration
The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74
We expect this to continue, which may increase the proportion of the population eligible to take these drugs, thereby increasing the population's health benefits
A video of Bruisers injection will be posted here shortly
The reward pathway recalibration Perhaps the most fascinating aspect of retatrutide appetite suppression is its effect on food reward processing